1-3 of 3
Xingzhe Ma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway

Qiang Wang, Zhijuan Lin, Zhuo Wang, Lingqun Ye, Miao Xian, Liuling Xiao, Pan Su, Enguang Bi, Yung-hsing Huang, Jianfei Qian, Lintao Liu, Xingzhe Ma, Maojie Yang, Wei Xiong, Youli Zu, Sai Ravi Pingali, Bing Xu, Qing Yi
Journal: Blood
Blood (2022) 139 (1): 59–72.
https://doi.org/10.1182/blood.2020009856
Published: 2022
Includes: Supplemental data
Journal Articles

MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma

Qiang Wang, Dongyu Zhao, Miao Xian, Zhuo Wang, Enguang Bi, Pan Su, Jianfei Qian, Xingzhe Ma, Maojie Yang, Lintao Liu, Youli Zu, Sai Ravi Pingali, Kaifu Chen, Zhen Cai, Qing Yi
Journal: Blood
Blood (2020) 136 (22): 2557–2573.
https://doi.org/10.1182/blood.2020005795
Published: 2020
Includes: Supplemental data
Journal Articles

Development of an Immunotherapeutic Monoclonal Antibody Recognizing DKK1-HLA-A2 Complex to Treat Human Hematologic Malignancies

Jianfei Qian, PhD, Qiang Wang, PhD, Lintao Liu, PhD, Enguang Bi, PhD, Xingzhe Ma, PhD, Pan Su, PhD, Maojie Yang, Qing Yi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5551.
https://doi.org/10.1182/blood-2019-123541
Published: 2019